PARC Projects

Provide protection against most harmful chemicals
PFAS in breast milk and infant health
Health effects
Human biomonitoring
Human health
Time span
-
Potential impacts
  • Detailed prevalence of an extended PFAS list in breast milk, blood and related matrices
Partners involved
LNS (LU)
BPI (GR)
JSI (SI)
MU (CZ)
RIVM (NL)
MUW (AT)
UGR (ES)
ONIRIS (FR)
UI (IS)
RSU (LV)
Contacts
Irene Fontes Marques (LNS)
Irene.Fontesmarques [at] lns.etat.lu
Konstantinos Kasiotis (BPI)
k.kasiotis [at] bpi.gr
Maria Torres Toda (LNS)
Maria.TorresToda [at] lns.etat.lu
Machera Kyriaki (BPI)
k.machera [at] bpi.gr
Key messages
  • Holistic PFAS biomonitoring in early development stage
  • Monitoring of newborns and pregnant women
  • PFAS exposure and pahtway gaps to be filled
  • Potential refinement of regulatory thresholds
Overview

This project implements a longitudinal human biomonitoring (HBM) survey to investigate exposure to per- and polyfluoroalkyl substances (PFAS) in the most vulnerable population: pregnant women and their newborns. It follows participants across three key time points, collecting various biological samples – with a strong focus on breast milk – to detect both known and emerging PFAS.

Researchers will analyse the samples to map exposure levels, identify trends, and characterise maternal transfer pathways during pregnancy and breastfeeding. By doing so, the project fills critical data gaps in PFAS research, particularly around exposure during early development.

The project targets multiple European countries, including Luxembourg, Greece, Czechia, the Netherlands, Austria, Slovenia, Spain, Cyprus, Iceland and potentially Latvia. It generates essential exposure data tailored to local populations, informing national and EU-level risk assessments. In turn, this helps regulators refine safety thresholds and update policies under REACH, the EU POP Regulation, and broader chemical safety legislation.

By actively contributing to the body of evidence on PFAS and its impact on human health, especially among sensitive groups, the project supports the EU Chemicals Strategy for Sustainability. It not only strengthens scientific understanding but also enhances the regulatory framework needed to manage PFAS emissions and safeguard future generations across Europe.

Filter by
Address chemical pollution in the natural environment
Provide protection against most harmful chemicals
Shift away from animal testing
Biodiversity protection
Streamlining data processing methods for suspect and non-target screening
Environment
Health effects
Human health
Monitoring methods
Risk assessment
NGRA
Mixtures
Human biomonitoring
Workers
Streamlining data processing methods for suspect and non-target screening
Streamlining data processing methods for suspect and non-target screening

PFAS in breast milk and infant health

Time span
-
Potential impacts
  • Detailed prevalence of an extended PFAS list in breast milk, blood and related matrices
LNS (LU)
BPI (GR)
JSI (SI)
MU (CZ)
RIVM (NL)
MUW (AT)
UGR (ES)
ONIRIS (FR)
UI (IS)
RSU (LV)
Key messages
  • Holistic PFAS biomonitoring in early development stage
  • Monitoring of newborns and pregnant women
  • PFAS exposure and pahtway gaps to be filled
  • Potential refinement of regulatory thresholds
Overview

This project implements a longitudinal human biomonitoring (HBM) survey to investigate exposure to per- and polyfluoroalkyl substances (PFAS) in the most vulnerable population: pregnant women and their newborns. It follows participants across three key time points, collecting various biological samples – with a strong focus on breast milk – to detect both known and emerging PFAS.

Researchers will analyse the samples to map exposure levels, identify trends, and characterise maternal transfer pathways during pregnancy and breastfeeding. By doing so, the project fills critical data gaps in PFAS research, particularly around exposure during early development.

The project targets multiple European countries, including Luxembourg, Greece, Czechia, the Netherlands, Austria, Slovenia, Spain, Cyprus, Iceland and potentially Latvia. It generates essential exposure data tailored to local populations, informing national and EU-level risk assessments. In turn, this helps regulators refine safety thresholds and update policies under REACH, the EU POP Regulation, and broader chemical safety legislation.

By actively contributing to the body of evidence on PFAS and its impact on human health, especially among sensitive groups, the project supports the EU Chemicals Strategy for Sustainability. It not only strengthens scientific understanding but also enhances the regulatory framework needed to manage PFAS emissions and safeguard future generations across Europe.

Contacts
Irene Fontes Marques (LNS)
Irene.Fontesmarques [at] lns.etat.lu
Konstantinos Kasiotis (BPI)
k.kasiotis [at] bpi.gr
Maria Torres Toda (LNS)
Maria.TorresToda [at] lns.etat.lu
Machera Kyriaki (BPI)
k.machera [at] bpi.gr
Topics
Provide protection against most harmful chemicals
Keywords
Health effects
Human biomonitoring
Human health